EU-Startups Funding· Rahul Raj·· 4 days agoTop DealsAI Score68
Amsterdam's VectorY Therapeutics raises €74.5M for ALS and neurodegenerative therapies
Amsterdam’s VectorY Therapeutics raises €74.5 million to tackle ALS and other neurodegenerative diseases
AI Overview
VectorY Therapeutics, an Amsterdam biotech, raised €74.5M ($83.5M) from new investors including Angelini Ventures.
Why it matters
The round shows which investors are backing AAV-delivered antibody therapies for ALS and Huntington's, and where the lead program stands in its Phase 1/2 trial.
Source:EU-Startups Funding · eu-startups.com